FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2865362922> ?p ?o ?g. }

• W2865362922 endingPage "2513" @default.
• W2865362922 startingPage "2504" @default.
• W2865362922 abstract "Purpose Testicular cancer (TC) treatment increases risk of subsequent malignant neoplasms (SMNs). It is unknown whether changes in TC treatment over time have affected SMN risk. Methods Solid SMN risk was evaluated in a multicenter cohort comprising 5,848 1-year survivors treated for TC before age 50 years between 1976 and 2007. SMN incidence was compared with cancer incidence in the general population. Treatment-specific risks were assessed using multivariable regression in a case-cohort design. Results After a median follow-up of 14.1 years, 350 solid SMNs were observed, translating into a 1.8-fold (95% CI, 1.6-2.0) increased risk compared with general population rates. Solid SMN risk was increased in patients with seminoma and those with nonseminoma (standardized incidence ratio, 1.52 and 2.21, respectively). Patients with nonseminoma experienced increased risk of SMNs of the thyroid, lung, stomach, pancreas, colon, and bladder and of melanoma and soft tissue sarcoma, whereas those with seminoma experienced increased risk of SMNs of the small intestine, pancreas, and urinary bladder. The 25-year cumulative incidence of solid SMNs was 10.3% (95% CI, 9.0% to 11.6%). In multivariable analysis, platinum-based chemotherapy was associated with increased risk of a solid SMN (hazard ratio [HR], 2.40; 95% CI, 1.58 to 3.62), colorectal SMN (HR, 3.85; 95% CI, 1.67 to 8.92), and noncolorectal GI SMN (HR, 5.00; 95% CI, 2.28 to 10.95). Receipt of platinum 400 to 499 and ≥ 500 mg/m 2 increased solid SMN risk compared with surgery only (HR, 2.43; 95% CI, 1.40 to 4.23 and HR, 2.42; 95% CI, 1.50 to 3.90, respectively), whereas risk was not significantly increased with lower doses (HR, 1.75; 95% CI, 0.90 to 3.43). The HR of a GI SMN increased by 53% (95% CI, 26% to 80%) per 100 mg/m 2 of platinum-containing chemotherapy. The HR of an infradiaphragmatic SMN increased by 8% per Gray of radiation dose administered (95% CI, 6% to 9%; P < .001). Conclusion Radiotherapy and platinum-containing chemotherapy are associated with increased solid SMN risk, specifically with GI SMNs." @default.
• W2865362922 created "2018-07-19" @default.
• W2865362922 creator A5009116808 @default.
• W2865362922 creator A5011423603 @default.
• W2865362922 creator A5012843588 @default.
• W2865362922 creator A5020911916 @default.
• W2865362922 creator A5023376896 @default.
• W2865362922 creator A5024839948 @default.
• W2865362922 creator A5027677772 @default.
• W2865362922 creator A5029408018 @default.
• W2865362922 creator A5030601121 @default.
• W2865362922 creator A5030962499 @default.
• W2865362922 creator A5032816632 @default.
• W2865362922 creator A5038546625 @default.
• W2865362922 creator A5041610986 @default.
• W2865362922 creator A5041739262 @default.
• W2865362922 creator A5042784431 @default.
• W2865362922 creator A5043581144 @default.
• W2865362922 creator A5047685910 @default.
• W2865362922 creator A5050890397 @default.
• W2865362922 creator A5051336739 @default.
• W2865362922 creator A5068826699 @default.
• W2865362922 creator A5072068921 @default.
• W2865362922 creator A5081011064 @default.
• W2865362922 date "2018-08-20" @default.
• W2865362922 modified "2023-10-17" @default.
• W2865362922 title "Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era" @default.
• W2865362922 cites W1903306466 @default.
• W2865362922 cites W1972908700 @default.
• W2865362922 cites W1979020186 @default.
• W2865362922 cites W1980473424 @default.
• W2865362922 cites W1981740919 @default.
• W2865362922 cites W1987604182 @default.
• W2865362922 cites W2017377152 @default.
• W2865362922 cites W2023273705 @default.
• W2865362922 cites W2038981426 @default.
• W2865362922 cites W2060372099 @default.
• W2865362922 cites W2065851070 @default.
• W2865362922 cites W2074355760 @default.
• W2865362922 cites W2076379009 @default.
• W2865362922 cites W2080839610 @default.
• W2865362922 cites W2083477789 @default.
• W2865362922 cites W2084312844 @default.
• W2865362922 cites W2099091477 @default.
• W2865362922 cites W2109175854 @default.
• W2865362922 cites W2111345124 @default.
• W2865362922 cites W2118502261 @default.
• W2865362922 cites W2121363159 @default.
• W2865362922 cites W2125784459 @default.
• W2865362922 cites W2129465453 @default.
• W2865362922 cites W2130803751 @default.
• W2865362922 cites W2149160937 @default.
• W2865362922 cites W2152710213 @default.
• W2865362922 cites W2156834485 @default.
• W2865362922 cites W2161993385 @default.
• W2865362922 cites W2166511246 @default.
• W2865362922 cites W2196766354 @default.
• W2865362922 cites W2261052167 @default.
• W2865362922 cites W2515981989 @default.
• W2865362922 cites W2529359491 @default.
• W2865362922 doi "https://doi.org/10.1200/jco.2017.77.4174" @default.
• W2865362922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29989856" @default.
• W2865362922 hasPublicationYear "2018" @default.
• W2865362922 type Work @default.
• W2865362922 sameAs 2865362922 @default.
• W2865362922 citedByCount "54" @default.
• W2865362922 countsByYear W28653629222018 @default.
• W2865362922 countsByYear W28653629222019 @default.
• W2865362922 countsByYear W28653629222020 @default.
• W2865362922 countsByYear W28653629222021 @default.
• W2865362922 countsByYear W28653629222022 @default.
• W2865362922 countsByYear W28653629222023 @default.
• W2865362922 crossrefType "journal-article" @default.
• W2865362922 hasAuthorship W2865362922A5009116808 @default.
• W2865362922 hasAuthorship W2865362922A5011423603 @default.
• W2865362922 hasAuthorship W2865362922A5012843588 @default.
• W2865362922 hasAuthorship W2865362922A5020911916 @default.
• W2865362922 hasAuthorship W2865362922A5023376896 @default.
• W2865362922 hasAuthorship W2865362922A5024839948 @default.
• W2865362922 hasAuthorship W2865362922A5027677772 @default.
• W2865362922 hasAuthorship W2865362922A5029408018 @default.
• W2865362922 hasAuthorship W2865362922A5030601121 @default.
• W2865362922 hasAuthorship W2865362922A5030962499 @default.
• W2865362922 hasAuthorship W2865362922A5032816632 @default.
• W2865362922 hasAuthorship W2865362922A5038546625 @default.
• W2865362922 hasAuthorship W2865362922A5041610986 @default.
• W2865362922 hasAuthorship W2865362922A5041739262 @default.
• W2865362922 hasAuthorship W2865362922A5042784431 @default.
• W2865362922 hasAuthorship W2865362922A5043581144 @default.
• W2865362922 hasAuthorship W2865362922A5047685910 @default.
• W2865362922 hasAuthorship W2865362922A5050890397 @default.
• W2865362922 hasAuthorship W2865362922A5051336739 @default.
• W2865362922 hasAuthorship W2865362922A5068826699 @default.
• W2865362922 hasAuthorship W2865362922A5072068921 @default.
• W2865362922 hasAuthorship W2865362922A5081011064 @default.
• W2865362922 hasBestOaLocation W28653629222 @default.
• W2865362922 hasConcept C121608353 @default.
• W2865362922 hasConcept C126322002 @default.

• next